Response to the letter to the Editor regarding Zeukeng et al.'s article A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an ... - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/29802425

Analysis of formulary coverage and cost of biologic disease modifying anti‐rheumatic drugs in Medicare Part D - Alghamdi - - Journal of Pharmaceutical Health Services Research - Wiley Online Library onlinelibrary.wiley.com/doi/abs/10.111…

Screening for Adverse Drug Events: a Randomized Trial of Automated Calls Coupled with Phone-Based Pharmacist Counseling linkedin.com/pulse/screenin…

Pharmaceutical Care in North America Lawrence Brown, Enrique Seoane linkedin.com/pulse/pharmace…

Pharmacy Econ Fellow kaiserpermanentejobs.org/job/downey/pha…

Innovation and competition in advanced therapy medicinal products embomolmed.embopress.org/content/early/…

New article on prescribing practices of ER opioids. Weaning ER opioids before admission did not impact pain or LOS. Postop: 4/5 pts using ER opioids prior to admission vs. 1/100 opioid-naïve pts received ER opioids @rmonguio Catherine Chen UCSF Anesthesia and Perioperative Care journals.lww.com/anesthesia-ana…

Study linking drug shortages to disruptions in clinical practice. link.springer.com/article/10.100… #pharmasupplychain #drugshortages @Rmonguio Tasce Bongiovanni, MD, MPP, MHS Catherine Chen Chapman University Chapman University Pharmacy

A Patient Price Guide for Prescription Medication to provide patients and clinicians access to drug price information. #DrugPrices #CostOfCare Professor Robin Feldman @UCHastingsLaw Brigham and Women's Hospital Chapman University Robin Feldman, Natalie Feldman, Enrique Seoane. acpjournals.org/doi/10.7326/M2…

🚨 New in Ideas & Opinions Annals of Int Med from Professor Robin Feldman, Dr. Natalie Feldman, and Enrique Seoane: A Patient Price Guide for Prescription Medication. buff.ly/3wNaSIK

We need a labeling system for pharmaceutical prices. Making drug prices transparent would help doctors know what to prescribe and ensure patients take their medications, by Professor Robin Feldman. Natalie Feldman, Enrique Seoane washingtonpost.com/outlook/2022/0… via Washington Post Opinions

Perspective | We need a labeling system for pharmaceutical prices. Professor Robin Feldman Enrique Seoane Armín Givechi Brigham and Women's Hospital Chapman University #DrugPrices #CostOfCare washingtonpost.com/outlook/2022/0…

Disentangling the Cost of Orphan Drugs Marketed in the US. Our study found significant increase in the number of new orphan drugs and a steady increase in prices that raise concerns about their affordability. mdpi.com/2227-9032/11/4… Chapman University UC San Francisco Chapman University Pharmacy

US Pays High Cost for Drugs Not Authorized or Reimbursed in Other Countries Unfavorable risk/benefit, uncertain benefit, or unacceptable price found in other countries for drugs that cost $115,281 patient/year in the US. Chapman University jamanetwork.com/journals/jamai…

Sixteen Years of Overregulation: Time to Unburden Mifeprex — NEJM nejm.org/doi/full/10.10…

Exploring the Potential for Using Drug Indications to Prevent Look-Alike and Sound-Alike Drug Errors tandfonline.com/doi/abs/10.108…

Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metform... bmchealthservres.biomedcentral.com/articles/10.11… #bmchealthservres

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication sciencedirect.com/science/articl…

Incorporating medication indications into the prescribing process ajhp.org/content/early/…